Health plan hails success of push to boost Remicade biosimilar use 22-Jan-2020 By Nick Taylor Health New England switched 93% of infliximab use to biosimilars after adopting a new policy.
Lonza works with Celltrion to ensure supply of Remsima drug substance 10-Sep-2019 By Ben Hargreaves Lonza’s facility in Singapore will provide Celltrion with the drug substance product to meet demand for the latter’s Remsima biosimilar in the European and US market.